Cargando…
Intrathoracic solitary fibrous tumor – an international multicenter study on clinical outcome and novel circulating biomarkers
Intrathoracic solitary fibrous tumor (SFT) is a rare disease. Radical resection is the standard of care. However, estimating prognosis and planning follow-up and treatment strategies remains challenging. Data were retrospectively collected by five international centers to explore outcome and biomark...
Autores principales: | Ghanim, Bahil, Hess, Sebastian, Bertoglio, Pietro, Celik, Ali, Bas, Aynur, Oberndorfer, Felicitas, Melfi, Franca, Mussi, Alfredo, Klepetko, Walter, Pirker, Christine, Berger, Walter, Harmati, Imrich, Farkas, Attila, Jan Ankersmit, Hendrik, Dome, Balazs, Fillinger, Janos, Aigner, Clemens, Hegedus, Balazs, Renyi-Vamos, Ferenc, Lang, György |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624895/ https://www.ncbi.nlm.nih.gov/pubmed/28970578 http://dx.doi.org/10.1038/s41598-017-12914-2 |
Ejemplares similares
-
Current therapy of KRAS-mutant lung cancer
por: Ghimessy, Aron, et al.
Publicado: (2020) -
Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma
por: Klikovits, Thomas, et al.
Publicado: (2017) -
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
por: Lohinai, Zoltan, et al.
Publicado: (2017) -
Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib
por: Ghanim, Bahil, et al.
Publicado: (2022) -
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma
por: Hoda, Mir Alireza, et al.
Publicado: (2016)